Axon Enterprise (NASDAQ:AXON) Releases Earnings Results

Axon Enterprise (NASDAQ:AXON) issued its quarterly earnings results on Tuesday. The biotechnology company reported $0.89 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.48), Zacks reports. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise updated its FY 2025 guidance to EPS and its FY 2025 guidance to EPS.

Axon Enterprise Trading Down 0.6 %

Axon Enterprise stock traded down $3.08 during mid-day trading on Tuesday, hitting $496.65. 1,295,552 shares of the stock were exchanged, compared to its average volume of 743,113. The stock has a market capitalization of $37.87 billion, a price-to-earnings ratio of 128.33, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise has a 12 month low of $265.32 and a 12 month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s fifty day simple moving average is $616.95 and its two-hundred day simple moving average is $520.78.

Analyst Ratings Changes

AXON has been the topic of a number of recent analyst reports. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a research report on Thursday, February 20th. Finally, JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $561.31.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the sale, the insider now owns 128,542 shares in the company, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,711 shares of company stock valued at $5,631,561. 5.70% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.